SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-009863
Filing Date
2004-11-12
Accepted
2004-11-12 13:55:21
Documents
5
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q PERIOD END SEPTEMBER 30, 2004 a03283e10vq.htm 10-Q 184053
2 EXHIBIT 31.1 a03283exv31w1.txt EX-31.1 4077
3 EXHIBIT 31.2 a03283exv31w2.txt EX-31.2 4163
4 EXHIBIT 32.1 a03283exv32w1.txt EX-32.1 1340
5 EXHIBIT 32.2 a03283exv32w2.txt EX-32.2 1408
  Complete submission text file 0000950137-04-009863.txt   197048
Mailing Address 5931 DARWIN COURT CARLSBAD CA 92008
Business Address 5931 DARWIN COURT CARLSBAD CA 92008 7604317080
IMMUNE RESPONSE CORP (Filer) CIK: 0000817785 (see all company filings)

IRS No.: 330255679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-18006 | Film No.: 041138014
SIC: 2836 Biological Products, (No Diagnostic Substances)